Pantoja, Ahmed AlZubaidi, Carlos Abril Vega, John Rodriguez, and Matthew Kroh
Key areas of research have included wound healing and tissue repair, collagen and elastin synthesis in skin models, gene expression effects (the Connectivity Map studies), antioxidant mechanisms, and hair follicle stimulation (for AHK-Cu)
, Phase 1 studies evaluated safety, tolerability, and pharmacokinetic characteristics Early data from Phase 2 investigations provided insights into biological activity and physiological responses
Side effects are uncommon and typically minor, such as a cool sensation in the arm or mild flushing
Your healthcare teampotentially including your primary care physician, endocrinologist, registered dietitian, and mental health professionalcan provide the comprehensive support needed for long-term success, whether you continue medication indefinitely or attempt maintenance without pharmacotherapy
Researchers believe theirs is the first published report following tirezepatide, sold under the brand name Mounjaro, which was approved in 2022 and is used for treatment of Type 2 diabetes and weight loss